Mr. Harris was named Senior Vice President, Marketing and Business Development in December 2018. He joined MiMedx as Senior Vice President, International in June 2018, bringing to the Company 20+ years of experience in the regenerative medicine, medical device and cell therapy fields. In this role, Mr. Harris is responsible for corporate and product marketing, partnerships and joint ventures, as well as international sales and operations.
Most recently, Mr. Harris served for two and a half years as Vice President & General Manager at Cytori Therapeutics, a pioneer in autologous adipose derived cell therapy. In this role, Mr. Harris was a named executive officer (NEO) with full responsibility for the global P&L and managed various functions within the company including its wholly owned subsidiary in Japan. Mr. Harris was actively engaged with investors, analysts & partners individually as well as participating in quarterly earnings calls. Prior to Cytori, Mr. Harris spent six years at Becton Dickinson’s Japan entity, and as the country CEO, he led an organization of over 600 employees, including a manufacturing & logistics center and a P&L in excess of $300M. He was a recognized leader during his time at BD, and served as a member of the Global BD Leadership Team and the BD Greater Asia Leadership Team. Mr. Harris was actively engaged externally, in elected leadership positions with the American Chamber of Commerce in Japan (ACCJ) and the American Medical Device & Diagnostics industry association (AMDD).
Mr. Harris’s background also includes global & regional leadership roles in product development, sales, marketing and market development with TE Connectivity, Delphi Medical Systems and Ballard Medical/Kimberly-Clark Healthcare (now Halyard Health). Mr. Harris is fluent in Japanese and received his BA and MBA from the University of Utah.